We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
Cap. Flow
+$1.82B
Cap. Flow %
2.24%
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$164M
2
MSFT icon
Microsoft
MSFT
+$157M
3
AMZN icon
Amazon
AMZN
+$75.7M
4
TSLA icon
Tesla
TSLA
+$50M
5
GEHC icon
GE HealthCare
GEHC
+$45.2M

Sector Composition

Rank Sector Weight
1 Technology 25.37%
2 Healthcare 13.58%
3 Financials 12.66%
4 Consumer Discretionary 10.75%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACLX
1976
DELISTED
Arcellx
ACLX
$1.43M ﹤0.01%
46,514
+3,525
+8% +$107K
UTZ icon
1977
Utz Brands
UTZ
$1.25B
$1.43M ﹤0.01%
86,666
+2,868
+3% +$47.5K
EGHT icon
1978
8x8 Inc
EGHT
$332M
$1.43M ﹤0.01%
342,068
+15,595
+5% +$78K
INDI icon
1979
indie Semiconductor
INDI
$854M
$1.42M ﹤0.01%
134,999
+10,894
+9% +$97.3K
ATNI icon
1980
ATN International
ATNI
$492M
$1.42M ﹤0.01%
34,755
+2,101
+6% +$92.8K
ROAD icon
1981
Construction Partners
ROAD
$6.77B
$1.42M ﹤0.01%
52,702
+3,476
+7% +$94.7K
UI icon
1982
Ubiquiti
UI
$34.3B
$1.42M ﹤0.01%
5,218
+37
+0.7% +$10.2K
ANIK icon
1983
Anika Therapeutics
ANIK
$287M
$1.42M ﹤0.01%
49,322
+3,497
+8% +$104K
BBBY
1984
Bed Bath & Beyond
BBBY
$442M
$1.42M ﹤0.01%
76,766
+1,615
+2% +$30.1K
ZETA icon
1985
Zeta Global
ZETA
$6.69B
$1.41M ﹤0.01%
130,263
+445
+0.3% +$4.29K
CHRS icon
1986
Coherus Oncology
CHRS
$196M
$1.41M ﹤0.01%
205,773
+10,159
+5% +$78.8K
EBF icon
1987
Ennis
EBF
$564M
$1.41M ﹤0.01%
66,698
+27,501
+70% +$588K
PLYM
1988
DELISTED
Plymouth Industrial REIT
PLYM
$1.4M ﹤0.01%
66,742
+2,512
+4% +$52.9K
RXRX icon
1989
Recursion Pharmaceuticals
RXRX
$1.73B
$1.4M ﹤0.01%
209,878
+4,291
+2% +$34K
TBRG
1990
DELISTED
TruBridge
TBRG
$1.39M ﹤0.01%
45,893
+2,069
+5% +$60.3K
PEBO icon
1991
Peoples Bancorp
PEBO
$1.47B
$1.38M ﹤0.01%
53,751
+952
+2% +$27.4K
MRC
1992
DELISTED
MRC Global
MRC
$1.38M ﹤0.01%
142,179
+9,456
+7% +$107K
RYAM icon
1993
Rayonier Advanced Materials
RYAM
$610M
$1.38M ﹤0.01%
220,080
+14,240
+7% +$99.3K
CWEN.A
1994
DELISTED
Clearway Energy Class A
CWEN.A
$1.38M ﹤0.01%
45,923
+575
+1% +$17.5K
GSHD icon
1995
Goosehead Insurance
GSHD
$2.32B
$1.38M ﹤0.01%
26,378
+1,161
+5% +$50.4K
PAR icon
1996
PAR Technology
PAR
$735M
$1.38M ﹤0.01%
40,557
+1,683
+4% +$56.1K
POWL icon
1997
Powell Industries
POWL
$7.71B
$1.38M ﹤0.01%
96,984
+5,676
+6% +$78.6K
CTKB icon
1998
Cytek Biosciences
CTKB
$546M
$1.37M ﹤0.01%
149,367
+6,804
+5% +$73.2K
RDFN
1999
DELISTED
Redfin
RDFN
$1.37M ﹤0.01%
151,499
+13,032
+9% +$97.2K
SPCE icon
2000
Virgin Galactic
SPCE
$398M
$1.36M ﹤0.01%
16,823
-43
-0.3% -$4.29K

Similar funds

RhumbLine Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
  • RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
  • RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
  • RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
  • RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
  • RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.

Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.